Product Program year 2019 Source: CMS Open Payments

Parsabiv

Biological Nephrology

NDC 55513-740-10

Open in the dashboard

General payments

$1,319,040

9,622 payments

Research payments

$554,132

84 payments

Through program year 2019, $1,319,040 in general payments and $554,132 in research payments were reported against Parsabiv (Nephrology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $1,319,040 9,622
2019 Research $554,132 84

Breakdown

Who paid General payments · program year 2019
  1. Amgen Inc. $1,319,040 9,622 payments
Top recipients General payments · program year 2019
  1. Marcos Rothstein Nephrology · Saint Louis, MO $91,589 7% · 155 payments
  2. Abdul Abdellatif Nephrology · Webster, TX $88,996 7% · 123 payments
  3. Christopher Gisler Nephrology · Pittsburgh, PA $68,130 5% · 106 payments
  4. Michael Quadrini Nephrology · Huntsville, AL $66,758 5% · 107 payments
  5. Anjay Rastogi Nephrology · Los Angeles, CA $64,428 5% · 93 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Nephrology Internal Medicine $1,252,476 98% · 2,639 practitioners
  2. Internal Medicine $13,412 1% · 156 practitioners
  3. Cardiovascular Disease Internal Medicine $5,344 <1% · 5 practitioners
  4. Hospitalist $732 <1% · 16 practitioners
  5. Family Medicine $607 <1% · 11 practitioners

The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $236,614 18% · 409 recipients
  2. Texas $165,303 13% · 269 recipients
  3. Missouri $151,754 12% · 57 recipients
  4. Pennsylvania $120,979 9% · 147 recipients
  5. Alabama $112,419 9% · 60 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

9,622 general · 84 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record